Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5 |
||
Inflammatory proteomics profiling for prediction of incident atrial fibrillation | ||
C. S. Börschel1, A. Ortega-Alonso2, A. S. Havulinna2, P. Jousilahti2, M. Salmi3, S. Jalkanen3, K. Kuulasmaa2, V. Salomaa2, T. Kempf4, T. Niiranen2, R. Schnabel1, für die Studiengruppe: FINRISK | ||
1Allgemeine und Interventionelle Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 2Finnish Institute for Health and Welfare, Helsinki, FI; 3Institute of Biomedicine, University of Turku, Turku, FI; 4Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover; | ||
Aims-Atrial fibrillation (AF) has emerged as a common condition in older adults. Traditional cardiovascular risk factors only explain about 50% of AF cases. Inflammatory biomarkers may help close this gap as inflammation can alter atrial electrophysiology and structure. The present study aimed to determine a cytokine biomarker profile for this condition in the community using a proteomics approach. Methods-This study uses cytokine proteomics in 10744 participants of the 1997 and 2002 FINRISK cohort studies, mean age 50.9 years, 51.34% women. Risk models for 46 cytokines were developed to predict incident AF using Cox regressions. In addition, the association of participants’ C-reactive protein (CRP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations with incident AF were examined. Results- |
||
https://dgk.org/kongress_programme/jt2022/aV1278.html |